Jenken Biosciences Receives FDA Clearance For Phase II Trial Of Lead Compound
Fri, 15 Dec 2006 08:00 AM EST
... Jenken Biosciences, Inc., an emerging specialty pharmaceutical company, today announced that the U.S. [click link for full article] ...
Related Topics
- Clinical Trials
- Creatinine Clearance
- Lead Poisoning
- Lead
- Aspirin and Carisoprodol
- Creatinine
- Blood Lead Levels
- Nystatin and Triamcinolone
- Food Recommendations: South Beach Diet - Phase 1
- Food Recommendations: South Beach Diet - Phase 2
- Poisoning
- Tacrolimus ointment
- Mammography
- Usher Syndrome: New Insights Lead to Earlier Treatment
- Kniest dysplasia
- Aspirin, Butalbital, Caffeine and Codeine
- Carcinogens
- Propoxyphene
- Long Term Care
- Juvenile Diabetes

Not Signed In -


